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Mixture toxicity is a topic that has become a matter of concern during the last two decades. One
of the major problems with assessing the toxicity of mixtures and the associated human and
environmental risk is the large number of possible mixtures, as well as the fact that the actual
mixture effect for a given set of constituents might strongly depend on the actual composition of
the mixture, i.e., the ratios of the constituent, as well as their nature. This paper presents a
possible approach to describe and thereby better understand the pharmacokinetics and dynamics
of complex mixtures by combining quantitative structure-activity relationships to predict needed
parameters, lumping to reduce the complexity of the problem, and physiologically based
pharmacokinetic/pharmacodynamic modeling to integrate all this information into a complete
toxicological description of the mixture. It is our hope that by presenting this conceptual approach
we might be able to stimulate some criticisms and discussions in the toxicology community
regarding this complex and yet very important area of research. Environ Health Perspect
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Introduction
Traditionally, both human and environ-
mental toxicologists have studied the toxic
effects (both lethal and sublethal, acute and
chronic) ofsingle substances. For decades,
the most important toxicological parameter
ofa compound, and the one that increas-
ingly should at least be determined, was
the so-called LD50, or median lethal dose,
for mammals and other terrestrial animal
species or the LC50, or median lethal aque-
ous concentration, for aquatic species
(including fish, crustaceans, and algae). As
the science oftoxicology advances, more
and more complicated testing methods are
developed and utilized, some ofwhich can
beextremelyanimal and resource intensive.
Over the last twenty years or so, how-
ever, it has become apparent that conven-
tional toxicologic methodologies are neither
practical for nor capable ofassessing the tox-
icity ofthe huge number ofsingle chemi-
cals, particularly the almost infinite number
ofchemical mixtures. Thus, protecting
both human and environmental health
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based on conventional toxicity testing may
not be achievable. There are two major
reasons for this problem.
First, there simply are too many differ-
ent chemicals to be adequately tested for the
large number ofrecognized orstill unknown
effects, especially on environmental health,
which requires measurements of effect
concentrations not only on single species
but also on complex biotic communities or
ecosystems. For example, the European
InventoryofExisting Commercial Chemical
Substances (EINECS) contains 100,000
individual entries (these are chemical prod-
ucts that are actually being marketed
(1); the Chemical Abstracts Registry con-
tains several million substances that have
been (tentatively) synthesized in labor-
atories (2); and the Aquatic Toxicity
Information Retrieval Database (AQUIRE)
created and maintained by the U.S. EPA
(3), the most comprehensive and reliable
source of aquatic toxicity data, contains
pertinent experimental data for about 5500
different chemicals.
Second, in real-life situations, humans
and the environment normally are not
exposed to single toxicants but to complex
mixtures oflarge numbers ofpotentially
hazardous and potentially interacting agents.
Some briefexamples illustrate this point.
First, consider some ofthe recent thinking
about the Persian GulfWar syndrome. It is
now hypothesized that the causative agent
for some reported illnesses might have been
a combination ofimmunization shots, anti-
nerve-gas prophylactics, insecticides, and
insect repellents, all ofwhich most Gulf
War veterans were expected to apply before
active duty (4,5). Alternatively, consider the
major die-offofharbor seals reported in the
Dutch and German section ofthe Wadden
Sea several years ago. The cause ofthe die-
off, which originally stumped marine mam-
mal researchers, finally appeared to be a
combination ofanormally innocuous mam-
malian virus infection and the immune sys-
tem dysregulating effect ofa high level ofa
complex mixture oforganochlorine com-
pounds, notably polychlorinated biphenyls
(PCBs), followed by opportunistic infec-
tions (6,7). Last, current understanding of
the potential ofpersistent chlorinated xeno-
biotics (such as PCBs, dieldrin, and toxa-
phene) to act as environmental estrogens
also indudes a strongly synergistic mixture
effect (8).
It has been recognized for some time
that one ofthe more promising approaches
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to dealing with the first problem, that of
the existence of too many compounds to
test for toxic effects, is the discipline known
as predictive toxicology. This is a discipline
that tries to predict the biological effects,
including but not limited to acute toxicity,
of chemicals from considerations of com-
pound structure and knowledge about the
target biological systems and subsystems.
Two tools predictive toxicology has devel-
oped over the years are quantitative struc-
ture-activity relationships (QSAR) and
physiologically based pharmacokinetic/
pharmacodynamic (PBPK/PD) modeling.
QSAR attempts to predict the qualita-
tive structure-activity (SAR) or quantitative
QSAR effect of a compound by analogy
with a number ofsimilar compounds (9).
SARs generally define a common substruc-
ture or overall shape similarity between
compounds with similar modes of toxic
action, using the presence or absence of
this substructure in an unknown com-
pound or the similarity ofthe unknown to
the known active compounds to predict
the likelihood of the unknown ofexhibit-
ing the same toxicity. QSARs attempt to
identify quantitative structural parameters
that correlate with the actual effect dose or
concentration that elicits a common effect
level (for example, LD50 or LC50).
PBPK/PD modeling approaches the
issue of predicting biological effects not
from the viewpoint ofa chemical but from
the viewpoint of a biological system.
Basically, what a PBPK model does is to
describe an organism (or a tissue or a cell)
as a connected system ofcompartments in
which mass balances, including transport
processes, diffusion exchanges, metabolic
and eliminatory clearances, receptor bind-
ing, etc., account for the uptake and dispo-
sition ofchemicals in this organism (10). If
the PBPK model is verified against experi-
mental data, the pharmacokinetics of the
compound can be predicted by the model.
This leads to two predictive improvements.
First, most of the chemical-specific para-
meters (blood-tissue and tissue-tissue par-
tition coefficients as well as metabolic and
elimination rate constants) for an unknown
can be determined in vitro and then used to
create a predictive model. Second, if the
biological specifics of an unknown target
organism are available, a model can be
adapted to predict the kinetics of a given
chemical of interest for this unknown
species. Furthermore, iffor a specifically
acting compound the pharmacodynamics at
the target organ or site (e.g., a cell or
enzyme) are known, these can be linked to
the predicted pharmacokinetics and the
complete PBPK/PD model can be employed
to predict effect levels for a certain toxic
effect. It has even been shown recently that
it is possible to incorporate the biological
variability found in nonclonal populations
of a species into a PBPK/PD model for
predictive toxicology by using Monte
Carlo simulation techniques (11,12).
We describe here an integrated predic-
tive toxicology approach that uses QSAR,
PBPK/PD, and lumping analysis tech-
niques to model the toxicologic effects of
complex mixtures of chemicals. This
approach is based on the concept that
PBPK/PD modeling not only can predict
the pharmacokinetics and dynamics ofsin-
gle compounds but is in principle also
technically capable of incorporating the
kinetics ofa number ofcompounds simul-
taneously. Moreover, if the pharmacody-
namics of these compounds are known
(from in vitro studies or from studies with
other species) and their possible interac-
tions with each other have been studied,
the overall toxic effect level ofany dose or
ratio ofthe mixture can, in principle, be pre-
dicted. QSAR techniques are instrumental
in predicting the necessary chemical input
parameters for unknown compounds such
as tissue-blood, tissue-tissue and blood-air
(or blood-water) partition coefficients,
metabolic rate constants and elimination
constants as well as possible pharmacody-
namic parameters such as binding affinities
and maximum turnover velocities for target
enzyme systems. These pharmacodynamic
parameters will in most instances automati-
cally yield interactive effects also, either
from competitive or noncompetitive bind-
ing to targets or from indirect interaction
between separate targets.
As mixtures get large (i.e., consisting of
more than, say 10 or 20 compounds),
however, several problems make even this
approach unworkable. For one thing, a
general lack ofexperimental data on indi-
vidual compounds can make model formu-
lation almost impossible. It becomes even
more difficult ifone attempts to develop a
model for a mixture ofunknown, partially
known, or undefined and changing com-
position such as a gasoline or jet fuel mix-
ture. Another limitation in the complexity
of the final model and thus in the total
number of compounds in a mixture that
can adequately be modeled is imposed by
the state ofthe current hardware, and even
more importantly, by the state of the cur-
rent software.* In all these cases the com-
plexity of the model must be reduced,
preferably by application ofeither intrinsic
or explicit lumping analysis. Lumping
analysis is a technique developed in the
petroleum industry to reduce the complex-
ity ofa model description ofa large mixture
to make reaction rate and reaction product
profile predictions for technical treatments
ofmixtures ofpetroleum products such as
the cracking ofa certain fraction ofa crude
(13). Lumping can be used to treat com-
pounds with the same or similar partition
coefficients as a single surrogate compounds
or to treat a set ofagonists on a target organ,
cell, or enzyme as a single agent with an
average affinity or turnover rate.
All three techniques mentioned above
will be described in more detail in another
section ofthis paper as will ways in which
these techniques might be combined into a
comprehensive predictive toxicological
approach. These techniques will be illus-
trated wherever possible by examples using
such complex mixtures as JP-5, automotive
gasoline, and other petroleum products.
Finally, an example will be given ofa tenta-
tive application ofall three techniques to the
toxicological modeling ofJP-5 exposure.
PBPK/PD Modeling
The uptake and disposition of chemicals
(drugs and pharmaceuticals) by living
organisms, most notably humans, long has
been one ofthe primary concerns ofphar-
macological research. The study ofthe dis-
persion of chemicals in animal bodies
constitutes the field ofpharmacokinetics-
although, depending on the type ofchemi-
cal studied, it has also been called toxicoki-
netics and biokinetics. For drug research,
two parameters ofthe disposition ofa drug
are ofspecial interest, namely the residence
time of a compound in the body (most
often reported as its half-life) and the (peak
or average or both) target concentration-
the amount ofthe drug that actually reaches
the pharmacodynamic target site and is
thus in principle available for therapeutic
(inter)action. Because of the limited
*Bear in mind that all these modeling approaches,
especially the PBPK paradigm, which relies heavily on
the numerical solution (approximation) of sets of
dependent differential equations, are subject to
approximation and roundoff error. The larger the model
description, the larger the total propagated error
becomes for a given level of precision; to keep the
level of error constant at a growing model size, the
precision level must go up as a function of model size
to a point at which this level of precision in combina-
tion with the limitations of the available hardware
make use of a model impractical.
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resources available for both detailed, time-
course in vivo concentration studies, and
for the computational effort needed, phar-
macokinetic investigators traditionally
described the pharmacokinetics of a com-
pound with data-based compartmental
models-they generally measure the time-
course ofthe compound's concentration in
a central compartment, normally blood,
hypothesize a number ofperipheral com-
partments of unknown size and chemical
disposition, and fit an n-exponential model
to the blood concentration versus time data,
with n being the number ofhypothesized
compartments (14).
Although this approach generally works
well if one has the data needed to fit the
model to, some researchers clearlywere dis-
satisfied with the apparent physiological
meaninglessness of the compartments and
compound rate constants that constituted
the n-exponential model. As early as 1937
Teorell (15,16) described a modeling
approach that rather than starting from
arbitrary data, started with a functional but
parsimonious physiological description ofa
living body. The approach divided the
body into key tissue groups, with connect-
ing blood flows providing inter-tissue trans-
port, and membrane permeabilities and
tissue partition coefficients describing the
distribution ofa compound over the differ-
ent physiological compartments. In these
original applications ofphysiologically based
modeling, one ofthe major drawbacks was
that to use the model, the set of linked
differential equations actually had to be
solved either analytically or by manually
performed numerical approximation tech-
niques. Consequendy, this approach evolved
only slowly during the next 40 years, until
in the 1970s, major advances in computer
hardware and software made possible for the
first time the solution from the desktop of
large sets ofdependent differential equations
needed to adequately describe a basic PBPK
model within a reasonable amount oftime.
So the basic difference between a classi-
cal pharmacokinetic model and a PBPK
model is as follows: In the classical model
not only the (compound) rate constants
and concentrations but also the actual lay-
out of the model (the topology of the
model, i.e., the number and size of the
compartments and the interconnections
between them) are dependent on the exper-
imental data (and thus on the chemical
under study, the setup of the experiment,
the route of exposure, and the dosing
regimen). In the PBPK model, on the
other hand, most if not all of the model
topology as well as many of the rate
constants and other chemical-dependent
parameters can be determined a priori. The
actual model topology can be determined
by considering the animal under study and
its physiology, the specific target for the
chemical (drug) under study and its physi-
ological location, and the specific meta-
bolic and eliminatory pathways known for
a drug; e.g., for a drug that is known not to
pass the blood-brain barrier, a separate
brain compartment is not needed for an
adequate, parsimonious PBPK model. The
chemical parameters needed for the ade-
quate description of its pharmacokinetics
can also be determined a priori; blood-air
and tissue-blood partition coefficients can
be measured in vitro by a number ofdiffer-
ent techniques [vial-headspace equilibration
for volatiles (17,18), dialysis equilibration
(19), or solid phase microextraction equili-
bration (20) for nonvolatiles]. Metabolic
rate constants, for either Michaelis-Menten
saturable degradation or for linear nth-
order (normally first-order) kinetics can also
be measured in vitro with, for example,
liver homogenates for liver-based metabo-
lism (21). When the model is complete, it
is checked against actual experimental
time-course data for the chemical and ani-
mal under study, and ifcorrespondence is
lacking, some of the parameters, within
physiological and chemical constraints, can
be adjusted to improve the model. Such a
PBPK model has two major advantages
over a classical model.
First, because it is based on the actual
physiology of an animal, it not only
empirically describes the concentration
time-course in the compartment actually
measured but also predicts the concentration
time-course in all the other recognized
compartments, notably the compartment
holding the active target for a drug. The
model in principle can even be refined to
where it will accurately predict the con-
centration of a pharmacon at the specific
target molecule.
Second, the model explicitly contains
the physiologic description of an animal
and the pertinent chemical parameters of
the compound under interest, actual cross-
species (or intra-species cross-lifestage) or
cross-compound predictions are possible. It
is this extrapolation possibility that makes
PBPK (and/or PBPD) modeling such a
promising tool in predictive toxicology.
So what does a basic PBPK model look
like? A basic mammalian model, assuming
exposure by inhalation to a volatile organic
compound, is made up of the following
compartments: lungs (the alveolar space
part ofthem); lung blood, where the com-
pound first enters the body proper; fat
(adipose) tissue (this normally acts as a stor-
age/sink compartment for lipophilic com-
pounds, with back-delivery); richly perfused
tissue (kidney, intestines, brain, liver)-
liver is normally separated from the rest of
the richly perfused tissue because it is the
compartment where the metabolism is nor-
mally located; and poorly perfused tissue
(mainly muscle and bone). Then there is the
blood, which is usually divided into arterial
blood, which leaves the lungs laden with a
chemical and enters the tissues where it will
redistribute it, and venous blood which
leaves the tissues depleted with a chemical
then returns to the lungs. The overall blood
flow is described by cardiac output and by
fractional blood flows entering the separate
compartments. For other exposure routes,
additional compartments can be defined
such as a skin compartment for dermal
uptake, a bulk bolus compartment for ip
injection, or a gut compartment for uptake
from food. Other elimination compart-
ments, in addition to exhalation through
the lungs, are the kidney for urinary excre-
tion, the liver for biliary excretion, or the
gut for direct desorption into fecal mass.
See Figure 1 for a schematic overview of a
basic PBPK model.
The model is linked mathematically by
means of mass balance equations that
describe movement ofthe compound from
blood to tissue or vice-versa by considering
the difference in concentration (or amount)
of chemical in the arterial blood entering
and the venous blood exiting a tissue
compartment (10):
dt4 = QC.- *(C/ lPbi) dt
This equation indicates that the rate of
change in amount ofchemical in compart-
ment i is a function of the blood flow to
compartment Qitimes the concentration in
the afferent blood Ca (what is coming in),
minus the blood flow from the compart-
ment (again Qi) times the concentration in
the efferent blood CilPb,i, defined as the
concentration in the tissue over the tissue-
blood partition coefficient (what is going
out); this description assumes that all com-
partments are internallywell mixed, and that
the efferent blood is in equilibrium with the
tissue (CGI = Ci/Pb,i). This type of basic
model is called a flow-limited model. Ifthe
assumption oftissue-blood equilibrium is
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Figure 1. Schematic overview of the main compart-
ments and blood and substance flows in a basic PBPK
model. Abbreviations: Qa,v. alveolar ventilation; Cinh,
concentration of compound in inhaled air; Caiv, concen-
tration of compound in alveolar air; 4t, cardiac output,
or total blood flow rate; Cart, concentration of com-
pound in arterial blood; Gm, Qf, Qr, Ql, blood flow rates
to individual tissues (Qf + Gm + Qr + Ql = QGO; CO, Cvm,
Cvr, Cvl, concentrations of the compound in the efferent
(venous) blood exiting the respective compartments;
Cven, concentration of compound in the venous blood
entering the lungs; Vmax, Km, Michaelis-Menten
kinetic constants. Figure adapted from Ramsey and
Andersen(22).
not met for one or more compartments, we
get a diffusion-limited model, in which two
differential equations are needed for each
compartment, one for the rate ofchange in
the tissue proper and one for the rate of
change in the tissue blood.
The major advantage of PBPK/PD
modeling for mixture toxicity work is that,
in principle, modeling the pharmacokinet-
ics ofa set ofmore than one compound is
mathematically the same as modeling the
kinetics ofa single compound. Fortunately,
the current state of computational tech-
nology in both hardware and software is
such that models ofsuch a complexity can
easily be solved, even from the desktop, ifa
powerful enough computer (high-end desk-
top system, e.g., employing Intel P5 or
Motorola PowerPC hardware or a worksta-
tion-type machine) is used. In the simplest
case, it is assumed that the individual
compounds do not interact at all. This
leads to a model that is nothing more than
a repetitious extension of a single com-
pound model, where the only mixture
toxicity integration performed is the possi-
ble adding of the multiple amounts at a
target site. This assumption, however,
while often quite useful in practice, violates
theoretical considerations in almost all
instances. Fortunately, a well-defined
PBPK/PD model can incorporate known
interactions between compounds at anyofa
number oflevels; a) at the level oftransport
kinetics, where they could compete for free
sites on transport proteins; b) at the level
ofmetabolism and elimination, where they
could either competitively or noncompeti-
tively inhibit each other's turnover by one
or more enzyme systems; and c) at the level
of the pharmacodynamics, where they
could competitively inhibit each other's
binding to an active site at a target enzyme,
or where one compound could display
noncompetitive inhibition or stimulation
ofthe action ofanother compound or even
act as an antagonist. In some cases interac-
tions of different compounds at disjoint
target sites could even ultimately have
interactive (synergistic or antagonistic)
toxic effects. If known, all these types of
interactions can in principle be provided
for in a PBPK/PD model.
Quantitative Structure-
Activity Relationships
Quantitative structure-activity relationships
originated in its current form within the
fields of agrochemistry and medicinal
chemistry. Both disciplines needed tools to
quantitatively correlate chemical structure
with biological activity, namely pesticide
action and specificity, and therapeutic
potency, both to rationalize congener selec-
tion and to guide the synthesis ofpotentially
more active or potent compounds. A num-
ber of researchers over the last 120 years
have used the inherent notions ofthe QSAR
discipline to explain or to model biological
activity of sets of compounds, notably
Crum-Brown and Frazer (23), Meyer
(24), Overton (25) and Ferguson (26),
but itwas not until Hansch et al. published
their seminal paper in Nature (27) that the
field got a theoretical foundation and a
solid start. Hansch et al. showed that for a
set of congeneric compounds a statistical
correlation could be found between a set of
structural parameters and the concentra-
tion at which any chemical from this set
elicited a certain set level ofa specific bio-
logic response (such as the LC50 concentra-
tion at which 50% of test organisms or
cells die) that is ofthe following form:
log (1/C) = a* + b*2+ c*+d*S+ e
where C is the concentration or dose at
which a certain effect manifests itselfat a cer-
tain level, 7i is a hydrophobicity term (later
superseded by log Ko,) encoding for hydro-
phobic interactions between, for example, a
molecule and a receptor site such as Van
der Waals interactions, £ is an electronic
term encoding for electronic interactions
such as ionic binding or dipole interactions
or hydrogen bonds, and S is a steric term
related to bulk and shape. The quadratic
term was introduced to empirically model
the observed curvilinear relationship between
log 1/Cand hydrophobicity frequently
encountered in single-dosing tests.
A number ofrationalizations have been
given for this basic QSAR equation, all of
which explicitly or implicitly rely on the
notions oflinear free energy relationships.
We will use the one given by Hermens
(28) because we believe it to be one ofthe
most illustrative rationalizations. Consider
that the activity of a biologically active
molecule can be described as being depen-
dent on a) the probability Pr, that a mole-
cule reaches its (proposed) target site; b)
the probability Pr2 that said molecule will
successfully interact with this target; c) the
dose, or external concentration C.
Ifwe then assume that at a particular
effect level the number ofmolecular events
that has occurred C, is constant, we can
easily see that:
ct = c *Pr, * Pr2 * C= constant
which, when log-transformed, becomes:
log(1/C) = c+logPr, +log Pr2.
Assuming then, without elaboration,
that the hydrophobicity term (log K0W)
from the Hansch equation, being a partition
coefficient, is a good indicator oflog Pr1,
the probability of a chemical reaching a
Environmental Health Perspectives - Vol 105, Supplement * February 1997 182PREDICTIVE APPROACH FOR THE TOXICITY OF COMPLEX MIXTURES
normally lipophilic site, and that the elec-
tronic and steric terms correlate to log Pr2,
the actual interaction with the target site,
for a set ofcongeneric molecules, the ratio-
nale behind the Hansch equation is clear.
Although QSAR analysis has been
used extensively in the pharmaceutical
field in the last 30 years, its application in
toxicology has lagged, with the notable
exception ofthe aquatic and related envi-
ronmental toxicology areas. This apparent
difference is probably because environ-
mental toxicologists have to deal with such
a large amount ofdifferent potential toxi-
cants, and often on such short notice that
the only way to provide information on
the biological action ofa chemical is to use
predictive techniques. Both in the phar-
maceutical/medicinal chemistry area of
QSAR and in the aquatic toxicology
QSAR field, important progress has been
made during the last 15 years so that for
large groups ofchemicals, predictions about
their pharmaceutical potency or their
environmental effect (level) can reliably
be made [for a recent overview, see either
Hermens and Verhaar (29) or Verhaar
(30)]-so much so that first and foremost
in the United States but also in Europe, a
substantial part ofthe environmental risk
assessment process makes extensive use of
QSAR predictions.
Some of the more important recent
advances in QSAR are the development of
more useful (user-friendly) and accurate
quantum chemistry codes (programs) that
can be used to calculate more adequate
physicochemical descriptors than before
(31), and can even be employed to calcu-
late reaction kinetics data for certain types
oftoxicological interactions (32), the intro-
duction of 3D-molecular modeling and
3D-QSAR methods that use actual 3-D
information about a (set of) molecule(s) to
predict receptor interaction and thereby
biological activity (33), and more advanced
correlation techniques such as partial least
squares (PLS) (34), analysis or neural net-
works correlations. PLS analysis can start
from a large set ofpotentially useful but
mostly highly collinear descriptors and cor-
relate these to one or more biological inter-
actions in such a way that the collinearity
between predictors is removed and the set
ofactual predictors is projected downward
to only a few significant ones, thereby cre-
ating correlative models with a high pre-
dictability. Neural networks, on the other
hand, can be trained on a descriptor and
biological effect set in such a way that they
will fit a closest nonlinear function to any
correlation without having to specify the
exact functional shape in advance.
Then what can QSAR do for PBPK
modeling, especially in the application of
PBPK modeling to mixtures? Consider that
even in PBPK modeling of single com-
pounds, for which a lot of experimental
data are available or generated specifically
for the modeling study ofinterest, a num-
ber of essential data frequently are not
known or are ofquestionable value, and are
often fitted a posteriori from comparison
(either manual or by a curve-fitting analy-
sis) with experimental pharmacokinetic
data. In such cases predictive methods,
especially iftheir applicability and reliablil-
ity are known, can fill in the blanks on an a
priori basis. In the case ofmixtures, espe-
cially large industrial mixtures, the chance
that all pertinent chemical information
needed for the modeling ofthe kinetics of
all the components decreases exponentially
with an increasing number ofconstituents
of the mixture, and a priori predictive
methods become almost imperative to the
PBPK modeling effort. The problem is
even worse when a modeling study must
deal with mixtures ofunknown or partially
known composition. No experimental data
can be used for constituents of unknown
nature, and predictions ofaverage chemical
parameters of the mixture must be either
based on a guess ofthe mixture's composi-
tion or on a carefully devised measurement
of some key physicochemical property or
property profile ofthe mixture.
The first and foremost property or
actual set ofproperties needed for the suc-
cessful development of a PBPK model are
the tissue-blood, and blood-air partition
coefficient for all involved compartments.
These normally are derived either from
(assumed) equilibrium in vivo situations
or measured in vitro, either by a vial head-
space equilibration method for volatile
compounds or with dialysis methods or,
more recently, SPME based methods for
nonvolatiles. This set of properties is,
within limits of chemical similarity,
amenable to QSARmodeling ofunknowns.
The work of de Jongh and co-workers
(35) showed that for a large set ofdiverse
chemicals, in both rats and humans, the
tissue-blood partition coefficients could be
described by a general function ofthe com-
pounds' log Ko,, ofthe following form:
Pt,b
OW
Kb
where Pt,b is the tissue-to-blood partition
coefficient,f,,, is the fraction ofwater in
the tissue,fJst is the fraction oflipid in the
tissue,fwb is the fraction ofwater in the
blood, fi,b is the fraction of lipid in the
blood, aand bare collander-type exponents
(these can be set to be the same also-they
denote the similarity ofthe different lipids
to octanol and to each other) and c is an
adjustment factor (mainly) to provide for
the effect ofprotein binding; this is most
pronounced for lowK,wcompounds.
The other area in which QSAR can be
used for PBPK modeling input is in the
prediction ofmetabolic rate constants and
elimination constants. Since these processes
depend on more types ofspecific interac-
tions than just physicochemical partition-
ing behavior, the QSAR predictions for
these parameters will be more specific to
certain types of chemicals and organisms
and will not be as generally applicable as
the tissue-blood partition coefficient
models. In fact, most ofthe QSAR applica-
tions in this particular field ofPBPK para-
meter prediction must be developed as this
field grows, since no specific models for
these types ofpredictions have been pub-
lished. Some general QSAR models for
metabolic rate constants have been pub-
lished [see, for example, (36)], but most of
this research is still in its infancy.
Lumping Analysis
Unlike PBPK/PD modeling and QSAR
analysis, lumping analysis is a discipline
with which most toxicologists are probably
not familiar. Therefore, it is discussed in a
little more detail in this section.
LumpingBasics
Modeling the pharmacokinetics and
pharmacodynamics ofa complete complex
mixture such as JP-5, a navy jet fuel, for
predictive toxicology purposes, would be
an extensive and perhaps impossible task in
terms of both the time and complexity
involved. A certain degree ofsimplification
is needed to bring such a project into more
realistic scope. This simplification can be
accomplished through a process called
lumping, in which similar components are
grouped (lumped) into pseudocompo-
nents. Whereas the actual mixture contains
too many components to follow individu-
ally, a set of a few well-chosen or well-
designed pseudocomponents could be
modeled. A representative chemical, or per-
haps a fictional average over the entire
pseudocomponent, would then be chosen
to substitute for each pseudocomponent to
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yield the necessary chemical parameters Once the initial best-guess lumping scheme
such as tissue partition coefficients and dif- is formulated, in some cases certain mathe-
fusion rates; the PBPK modeling is then matical methods exist to estimate the error
performed on these pseudocomponents. introduced in transforming the individual
The general concept oflumping involves chemicals to the lumped groups or from
taking a mixture ofseveral chemicals and one scheme to another (37). This is dis-
finding some relevant similarity that allows cussed further in the section "Two General
the grouping of certain chemicals. For Cases." The scheme is then adjusted to
example, in a mixture of eight chemicals limit the error as deemed necessary by the
(A1, A2, A3, B1, B2, C1, C2, C3), imagine particular situation. The ideal situation
that all ofthe As behave in a similar manner would be one of invariant response, i.e.,
in the process of interest, and the same fol- one in which the behavior ofthe system is
lows for the Bs and the Cs. Then the eight not changed as the concentration ratio of
chemicals could be grouped into three new chemicals within a given pseudocomponent
pseudocomponents A, B, and C, so that the is changed. Ifall the chemicals in a pseudo-
mixture can be considered to contain only component behaved in exactly the same
three relevant chemicals (Figure 2). manner, this would be the case; however,
How the chemicals are lumped depends this situation rarely ifever occurs.
on the behavior of the chemicals being Depending on the characteristics ofthe
studied. In petroleum production processes system of interest, different methods of
where cracking or breaking apart the large lumping may be used. Some ofthese are
molecules and subsequent distillation are * A system can be described as either per-
the most important issues, the molecular fectly or imperfectly lumpable. Ifa sin-
weight or the boiling point might be the gle lumping scheme can be used to
basis ofgrouping. In other situations, the describe all subprocesses ofthe system,
octanol-water partition coefficient Kow or such as characterizing the inlet stream,
key structural features might be more the intermediate kinetics, and the out-
important. Regardless of the parameter let stream, then it is considered per-
used, a first-guess lumping scheme is gener- fectly lumpable (38).
ally based on intuition. In instances where * A lumping scheme can be either proper,
these parameters are not known for some of semiproper, or improper. Ifeach chemi-
the chemicals involved, their values can cal is put entirely into one pseudocom-
often be predicted by methods like QSAR. ponent or another, then the scheme is
Since the chemicals in a pseudocompo- proper. However, if50% ofchemical A
nent have individual identities, they will is put in one pseudocomponent and
not truly behave as a single chemical. Thus, 50% is put into a different pseudocom-
lumping leads to a loss of information. In ponent, then the scheme is either semi-
creating a lumping scheme, one must proper or improper (38). Most of the
weigh the advantage ofthe ease ofdealing mathematics describing lumping deal
with a smaller number of pseudocompo- strictlywith proper schemes.
nents against the disadvantage of the Lumping can be performed in either a
increased loss ofinformation describing the discrete or a continuous method. The
system. A balance must be found between example in Figure 2 was discrete: certain
these two competing factors, and that specific chemicals were placed into cer-
balance will be unique for each situation. tain lumps. However, with a very large
mixture ofchemicals, a more continuous
method might be used. An example of
8 Chemicals 3 Lumps this would be to place all chemicals with
A1 molecular weights of0 to 100 in pseudo-
A A component A, and those with molecular A2 A weights of 100 to 200 in pseudocompo-
A3 nent B. In this manner, the actual num-
B1 ber or identity of the chemicals in the
B = > B pseudocomponent may not be known.
B2 In a truly continuous lumping scheme,
C1 no discrete pseudocomponents exist.
C2 > * c Rather, all the chemicals are described in
/3 a continuum [(39), see also the example
in the nextmajorsection)].
Figure 2. Lumping scheme to lump eight chemicals As with any method ofanalysis, varying
intothree pseudocomponents. degrees of complexity exist. For example,
although many ofthe processes deal strictly
with reaction kinetics, some processes must
also consider additional processes such as
mass transfer. This is evident in the petro-
leum industry, where reaction kinetics may
be increased by a catalyst. In this case, mass
transfer is in the form ofdiffusion on a cat-
alyst particle. This adds another level of
complexity to the mathematics; and one
that may become important in lumping
analyses for PBPK modeling. A second
complexity-enhancing aspect oflumping
analysis involves precisely the reaction
kinetics. The simplest oflumping schemes
considers only first-order reaction kinetics;
others also consider higher-order reactions.
Sometimes higher-order reactions can be
estimated as first-order, depending on the
situation and the accuracy required.
LumpingTheory:Two General Cases
As discussed previously, several different
levels oflumping exist; in fact, not all sys-
tems can be lumped in the same manner.
However, two general cases exist. In the
first case, all the chemicals involved in the
system are well identified, and their behav-
ior with respect to each other is known
quantitatively (i.e., reaction kinetic rate
information is available). A catalytic crack-
ing process in the petroleum industry is an
example of this case; this process will be
illustrated later. In the second case, how-
ever, the mixture of chemicals involved is
not explicitly defined, that is, the identities
of the chemicals are not (exactly) known,
and their behavior has not been described
quantitatively or even qualitatively.
Lumping analysis was first introduced
by Kuo and Wei (37) and Wei and Kuo
(38) in the 1960s. They presented a math-
ematical approach to lumping a well-
defined mixture of chemicals. To give a
better understanding ofthis mathematical
process oflumping analysis, a simplifica-
tion ofan example illustrated in their work
is given here, along with the basic mathe-
matics needed to describe it. More specific
and complete information is provided in
their original papers. k
For a single reaction: x-*y, the react-
ing species is x, and the rate of reaction is
k. With reversible reactions and multiple
interrelated reactions, a matrix format
helps to reduce the number of equations
and simplify the mathematics. In case 1,
these reactants and products, as well as the
reaction kinetics that link all species, are
known. Consider the linear reaction system
involving three species Al, A2, and A3,
described as follows (Figure 3).
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A1
4'
k12
k2l
A3
Figure 3. Linear, reversible reaction system of three
species.
For this system, the actual species
composition matrix (a matrix that includes
all species involved, both reactants and
products) is
[aj
a= a2
ka3
where ai is the fractional composition of
species Ai. Ifwe seek to lump together a,
and a2 (because ofsimilarities in behavior)
into d2 such that a, + a2 = d, (and a3= d2),
then the lumped composition matrix is
(a)i
a2
The lumped reaction system between
A1 andA2 could be illustrated as:
A
k12,
A A2
A
k2l
The lumping matrix M is used to
mathematically relate the lumped species
matrix to the unlumped species matrix.
For the example, the lumping matrix is
defined by
d=M* a
so that
Differential equations are used to
IA2 mathematically describe the concentrations
ofthe chemical species as they change with
time. In a first-order reaction, the deriva-
tive ofthe concentration is expressed as the
product of the concentration itself and a
reaction rate, as shown:
= -ka
dt
dt
Since the concentrations of the chemi-
cal species are expressed in matrix form,
the reaction rates must also be expressed in
matrix form. For the original species, the
unlumped rate matrix is,
kil -k12 -k13
K= -k2I Iki2 -k23
I-k31 -k32 Xki3
and the lumped rate matrix for the lumped
species is
K k21 k12J
Other matrix manipulations take off
from this point, and the papers by Wei
and Kuo (38) and Kuo and Wei (37)
illustrate other valid mathematics that
apply to this example. Even from the lim-
ited mathematics presented here, it is
evident that much has been gained by
lumping. Originally, three different species
had to be considered, along with the three
reversible reactions that connected them.
However, with the new pseudocompo-
nents, only two species have to be consid-
ered, and now there is only one reversible
reaction. Thus, from lumping, the matri-
ces to be manipulated are considerably
smaller and less subsequent computation
will be required. Although this was a very
simple example, it is apparent that with
larger systems (those with five or ten or
hundreds ofcomponents) the simplification
could be immense.
A real-world example of such a well-
defined lumping system is the Mobil
10-lump model, which was developed
for catalytic cracking processes in the
petroleum industry. This model is illus-
trated in Figure 4.
In this model, the many petroleum
compounds involved have been lumped
into ten groups according to similarities in
molecular structure and boiling point.
Catalytic cracking is the decomposition of
larger molecules into smaller molecules to
achieve a more useful product, gasoline.
However, only a fraction of these smaller
molecules comprises the gasoline lump;
those molecules even smaller than those in
gasoline are grouped in the C lump.
Average reaction kinetics have been deter-
mined for each of the reaction arrows
shown in the diagram, so this system can
be mathematically described in a manner
similar to the matrix example described
previously (13).
The Mobil 10-lump scheme has been
shown in the petroleum industry to be the
most effective for the situation in which it
is used, but, ofcourse, an infinite number
ofpossible schemes exist in theory. The key
to lumping is to choose the lumping scheme
that provides simplicity while maintaining
a level of accuracy deemed necessary for
the particular situation. For systems that
fall into case 1, the well-defined case, there
exists a mathematical means ofdetermining
the error introduced as additional groups
are lumped together. Known as cluster
analysis, this method is based on a set of
statistical equations (13). The error intro-
duced with each additional reduction in
system complexity (i.e., in going from 10
to 9 to 8 to 7 lumps) can be calculated,
and the point at which the error exceeds an
arbitraryacceptable level can be determined.
Systems for which most or all of the
relevant properties are unknown (case 2)
are more difficult to describe mathemati-
cally. Information on the chemical species
present and their behavior is lacking, so a
different approach must be taken in analyz-
ing this type ofsystem. Informed assump-
tions form a basis in this type of analysis.
For simple mixtures containing a relatively
small number of known chemicals (e.g.,
less than 20) for which parameter values
are unknown, a QSAR method can be used
to estimate those values (see the QSAR sec-
tion) and a discrete lumping method can
be performed over the estimated parame-
ters. For most complex mixtures such as
gasoline orJP-5 (a naval jet fuel), the iden-
tity and concentration ofeach component
may be unknown; even the total number of
major and minor components might not
be readily available. Thus, discrete lumping
and classical QSAR methods cannot be
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Figure 4. Schematic of the Mobil 10-lump scheme. Each lump reacts to yield the product pointed to by the arrow.
[Redrawn from Coxson and Bischoff (13)]. The ten lump species are PH, wt% paraffinic molecules, 6500 F+; NH,
wt.% naphthenic molecules, 6500 F+; SH, wt% aromatic side chains, 6500 F+; AH, wt % carbon atoms among aro-
matic rings, 6500 F+; PL. wt % paraffinic molecules, 430 650° F; NL = wt % naphthenic molecules, 430 650° F; SL,
wt % aromatic side chains, 430 650° F; AL, wt % carbon atoms among aromatic rings, 430 650° F; G, gasoline
lump(C5-430° F); C, C-lump(Cl to C4 +coke).
used. Instead, a feasible approach is to use
available information on the mixture as a
whole (i.e., boiling points of fractions or
the boiling range and behavior) in QSAR
models to estimate continuous parameter
value distributions that then form the basis
for a continuous or semicontinuous lump-
ing scheme. It may also be possible to use
QSAR estimates in the cluster analysis
method to provide guidance in developing
the lumping scheme.
For example, the naval jet fuel JP-5 is
composed ofhundreds ofcompounds, but
the exact composition has not been deter-
mined and actually can vary considerably
depending on origin ofcrude employed,
specific method to formulate the final prod-
uct, and actual provider/refiner. However,
general knowledge about the composition,
such as general composition groups, is avail-
able. Using this information in conjunction
with certain known properties ofJP-5 (such
as boiling and freezing points), a good guess
can be made for the composition ofJP-5
(see the section on Integration). Using this
information, the components can be
lumped according to known or estimated
properties that might dictate the behaviour
of interest ofthe system (such as lumping
by Kow, to analyze distribution within a
physiological system).
Frequently, a more continuous approach
to lumping (such as in the previous exam-
ple) is helpful with ill-described systems. In
this way, lumps can be made, but the exact
composition of each lump need not be
known. Rather, using information available
for a particular group ofcompounds, aver-
age parameters maybeassigned to thelump.
Application ofLumpingAnalysis
to PBPKModeling
Using lumping analysis in a PBPK model of
a complex mixture involves several aspects
not present in traditional petroleum lump-
ing analyses. For example, a single lumping
scheme may not suffice for the entire model,
which implies a need to use imperfect lump-
ing. A likely scenario is that one lumping
scheme may be appropriate for the pharma-
cokinetics ofdistribution ofthe mixture in
the body, while a second scheme may be
necessary to describe the pharmacodynam-
ics ofthe chemicals involved (Figure 5).
This improper lumping approach is
also illustrated in Figure 6 as a very general
compartmental diagram. Scheme 1, the
pharmacokinetic scheme (which lumps
those chemicals with similar pharmacoki-
netic fate), is designated by the solid
arrows, and scheme 2, the dynamic scheme
(which lumps those chemicals with similar
Kinetic
lumping
scheme
Original
8 chemicals
Dynamic
lumping
scheme
Figure 5. Schematic of imperfect lumping.
Respiration
Oral dose
Metabolism
Figure 6. General compartmental diagram of imperfect
lumping scheme incorporated into PBPK/PD modeling.
pharmacodynamic fate), is designated by
the dashed arrows. The relumping between
schemes is done computationally.
Another issue to consider in PBPKmod-
eling ofcomplex mixtures is interactions
between the lumps. Interactions between
lumps can be modeled just as they are for
interactions between single chemicals.
Interactions can be additive, synergistic, or
antagonistic (40). No matter what type of
interactions exist, each lump is treated as a
single chemical. Thus, the lumping scheme
must be chosen in such a way that interac-
tions between lumps can be described in
this manner and thatsignificant interactions
do not occurwithin apseudocomponent.
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As an example, a general procedure
addressing the PBPK/PD modeling of a
general complex mixture, here the naval jet
fuelJP-5, is outlined below.
* Determine a first-pass proper lumping
scheme: JP-5 is composed ofmany dif-
ferent chemicals; thus, the initial analy-
sis will be a semicontinuous form of
lumping. That is, based on our knowl-
edge of the composition ofJP-5, we
will separate the major or significant
components into discrete lumps. If it
becomes evident at a later date that a
continuous analysis would be more
appropriate, it can be further investi-
gated at that time.
* Formulate the PBPK/PD model,
including reaction kinetics and mass
transfer. For the reaction kinetics, it
may be much easier to assume first-
order kinetics; however, Michaelis-
Menten kinetics are often implicated in
the metabolism ofchemicals. With ini-
tial models first-order kinetics may be
assumed. However, more accuracy can
be incorporated into subsequent mod-
els. The mathematics required to incor-
porate the mass transfer inherent in a
PBPK/PD model can be based either
on simple partition coefficient schemes,
such as that shown later in the JP-5
example, or, in more complex cases, on
those used with diffusion on a catalyst
particle. Several papers in the literature
address this issue in the petroleum
industry (38,41).
* Evaluate performance and consider the
addition ofcomplexities: As with any
situation, the initial PBPK/PD model
is a simplified version of reality. To
increase the accuracy of the model,
interactions in the reaction kinetics
and an improper lumping scheme may
be included.
Integration: An Example
Using JP-5, a NavyJet Fuel
Introduction
JP-5 is a jet fuel of the kerosene type. It
can be formulated from both crude petro-
leum and shale or from other synthetic
crudes. It is intended to be used in Navy
jet fighters, mainly deployed from aircraft
carriers, and thus is subject to certain
specifications to ensure its suitability for
storage and use on board marine vessels.
The major requirement specific to JP-5 is a
rather high limit flashpoint of600C. This
requirement immediately points to the
main difference between JP-5 and JP-4, a
wide-cut kerosene-type jet fuel that is
almost identical to commercial Jet-A and
heating fuels 1 and 2 (the difference is the
narrower and higher boiling range ofJP-5
vs JP-4). JP-4 has a cut range ofapproxi-
mately 120 to 280°C, whereas JP-5 has a
cut range ofapproximately 200 to 290°C.
Consequently, JP-4 and other wide-cut
kerosenes contain hydrocarbons ranging
from C4 to C16, while JP-5 and similar
narrow-cut kerosenes contain hydrocar-
bons in the C9 to C18 range.
Composition
Since JP-5 is a product that is formulated
based on certain physical and physico-
chemical properties rather than on actual
chemical makeup, considerable variation
exists in actual JP-5 composition, caused
mainly by differences in crude feed mater-
ial and refinery-specific methods used in
creating a product that adheres to the
required specifications. Roughly speak-
ing, a JP-5 sample will consist of petro-
leum-derived hydrocarbons, generally
some 100 to 300 different constituents,
plus a number of property-enhancing
additives that constitute a very minor
amount on a weight/weight basis. Most if
not all JP-5 stocks can be considered to
have roughly the following composition,
according to sources pertaining to jet fuel
composition (42-45).
Hydrocarbon fraction
* Paraffins (alkanes)
30 to 40% (6-8% n-paraffins; C9-C18)
* Olefins (alkenes)
1 to 4%
* Aromatics
± 20% (almost no PAHs; highly substi-
tuted)
* Naphthenes (cycloalkanes and
cycloalkenes)
30 to 50%
* Nitrogen compounds
< 0.3%
* Sulfur compounds
± 0.1% (mostly disulfides R-S-S-R)
Known additives
* Diethyleneglycol monomethylether
(anti-icing agent)
* Dicarboxylic acids (anti-corrosives)
* Hindered phenols (anti-oxidants)
* N,N'-disalicylidene-1,2-propanedi-
amine (metal chelator)
A partial compositional breakdown of
JP-5 is also available (46). This describes
about 36% ofthe composition ofJP-5 on a
weight basis. This partial composition
information can be used to estimate a
chemical profile for JP-5 as a whole. See
Table 1 for an overview of the known
composition ofJP-5. Figure 7 shows the
distribution ofmole fractions over log Kow
windows based on the composition pre-
sented in Table 1 (light bars) and based on
a hypothetical composition assuming that
the unaccounted for compounds follow
hydrophobicity profiles similar to that of
the known compounds.
SystemsTo BeModeled
Since JP-5 can be both a potential human
health hazard (as in acute or chronic
exposure ofpetroleum industry workers,
fuel and airplane technicians, and aviators
to jet fuel fumes or liquid present in their
normal working environment (47,45,48),
as well as members of the general public
following major spills, from continuous
leaks or evaporative loss from contami-
nated sites), and an environmental health
hazard (as air, water, or soil pollutant), it
should be decided beforehand what biolog-
ical system will be modeled andwhy.
Since it is more likely that JP-5 poses a
health threat to workers who are occu-
pationally exposed to it than that JP-5 will
feature in a major environmental contami-
nation, it appears that modeling human
health effects would be the most appro-
priate action. Ifso, it can safely be assumed
that human exposure will in most instances
be inhalatory in nature-ingestion of
appreciable amounts ofJP-5 is an unlikely
occurrence other than possibly in calamity
situations. Dermal exposure long and
severe enough to pose a significant threat
to human health is fairly unlikely but
could in principle be experienced by
maintenance and fuel delivery workers
both in processing, transporting, and
shipping enterprises and by maintenance
personnel for navy jet fighter assemblies.
Therefore, our first choice is to try to
model distribution and effects following
acute and chronic inhalatory exposure,
with transdermal exposure situations a
close second. An added benefit of includ-
ing dermal exposure routes in a PBPK
model-based risk assessment is that from
target-effect levels determined or calcu-
lated for, for example, inhalatory expo-
sure, coupled with reliable data on
transdermal transport ofa toxicant, exter-
nal effect levels can be accurately deter-
mined for this exposure route. The same
is true for other exposure routes, hence
the ability ofgood PBPK models to assist
in route-to-route extrapolation.
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Table 1. Partial composition ofJP-5, based on American Petroleum Institute (46).
Compound Molar mass JP-5, % Mole fraction, % ClogP
Octane 114 0.12 0.082135 4.93
Nonane 128 0.38 0.292035 5.455
Decane 142 1.79 1.526101 5.984
Undecane 156 3.95 3.699675 6.513
Dodecane 170 3.94 4.021491 7.04
Tridecane 184 3.45 3.81135 7.571
Tetradecane 198 2.72 3.233523 8.1
Pentadecane 212 1.67 2.125662 8.63
Hexadecane 226 1.07 1.451891 9.16
Heptadecane 240 0.12 0.172916 9.69
3-Methyloctane 128 0.07 0.053796 5.325
2-Methylundecane 170 1.39 1.418749 6.912
2,6-Dimethylundecane 184 2 2.209478 7.311
1,3,5-Trimethylcyclohexane 126 0.09 0.068086 4.911
1,1,3-Trimethylcyclohexane 126 0.05 0.037825 4.911
n-Butylcyclohexane 142 0.9 0.767313 5.46
Heptylcyclohexane 184 0.99 1.093692 7.05
m-Xylene 106 0.13 0.082735 3.14
o-Xylene 106 0.09 0.057278 3.09
1,2,4-Trimethylbenzene 120 0.37 0.266578 3.589
1,3-Diethylbenzene 134 0.61 0.490768 4.198
1,4-Diethylbenzene 134 0.77 0.619494 4.2
1,2,3,4-Tetramethylbenzene 134 1.48 1.190717 3.98
1-Ethylpropylbenzene 148 1.16 1.03077 4.73
1,2,4-Triethylbenzene 162 0.72 0.700309 5.18
Phenylcyclohexane 160 0.82 0.787727 4.76
1-t-Butyl-3,4,5-trimethylbenzene 176 0.24 0.25361 5.37
n-Heptylbenzene 176 0.27 0.285311 5.82
n-Octylbenzene 190 0.78 0.889795 6.34
Naphthalene 128 0.57 0.438053 3.316
2-Methylnaphthalene 142 1.38 1.176547 3.815
1-Methylnaphthalene 142 1.44 1.227701 3.815
2,6-Dimethylnaphthalene 156 1.12 1.049022 4.314
Biphenyl 154 0.7 0.647233 4.03
1-Ethylnaphthalene 156 0.32 0.299721 4.34
2,3-Dimethylnaphthalene 156 0.46 0.430848 4.26
Tridecene 182 0.45 0.491729 7.09
a,
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Figure 7. Distribution of tentative JP-5 mole fractions over 1 log unit log K0, windows from 3 to 10. Light-colored
bars are for percentages based on the fact that the JP-5 composition on which this exercise was based
represented some 36% of its total mass; dark-colored bars are based on the assumption that the missing 64% is
proportionally distributed over the recognized windows.
WhatData/ParametersAreNeededTo
AdequatelyModelthePBPKBehavior
ofJP-5 afterInbalaoryExposure?
Since we are interested, at least initially, in
the modeling ofJP-5 after inhalatory expo-
sure, the first thing needed is either avolatil-
ity profile ofJP-5 or (more likely) data on
the actual constitution ofJP-5 vapor. This
could probably be obtained byanalyzing the
constitution ofJP-5 headspace vapor instead
ofliquid JP-5 samples, wherever in subse-
quent sections mention is made ofactual
measurements onJP-5 material.
The next set of data needed is an
overview of PBPK-relevant (air-blood,
blood-tissue) partition coefficients forJP-5
constituents. Another set ofdata called for
consists of (qualitative or quantitative)
information on biotransformation (metab-
olism) ofJP-5 constituents.
Finally, effect parameters are needed to
model specific toxicological end-points such
as reactivity parameters for olefins that
might be present in JP-5 and carcinogenic-
ityparameters for possible residual PAHs.
KnownToxicologicalEffect ofJP-5
Expected but not Substantiated Effects.
Some research has been done on the possible
toxicological effects of human and animal
exposure to JP-5; human exposure has
been focused mainly on inhalatory effects
from JP-5 vapors, whereas animal studies
(rats and mice) have been performed for
inhalatory exposure as well as gavage dosing,
dermal application, and intravenous admin-
istration (48). The main conclusions that
can be drawn from the results presented for
these studies are as follows:
According to a mouse dermal appli-
cation study (49) as well as a Salmonella
typhimurium mutagenicity test (49), JP-5
seems to be noncarcinogenic. This is some-
what surprising given the fact that a similar
diesel fuel marine (DFM) is carcinogenic.
The difference might be that, unlike DFM,
JP-5 contains almost no polycyclic aromatic
hydrocarbons (PAHs) (48).
JP-5 and other kerosene products have
an animal-specific renal toxicity to the male
rat. Since this effect is directed to a unique
rat protein, namely a2)i-globulin, which is
pheromone-related, it is highly unlikely that
JP-5 will exhibit such renal toxicity to species
other than rat, induding humans (50,44).
Although not reported, toxic effects
could in principle be expected from the
known additives to JP-5, since all additives
are known toxicants (42,49,48). It should
be noted here that the additives are present
in very small quantities and that they are
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all highly nonvolatile. It therefore seems
highly unlikely that effects would be seen
after inhalation exposure to JP-5 vapors.
Exposure to these additives is to be antici-
pated after transdermal or oral exposition,
but so far no indication for the subsequent
occurrence of toxic effects has been found
in gavage or dermal application animal
studies (48,44).
Target Organ Effects. Studies ofJP-5
target organ effects have included the
hematopoietic system. In a series ofstudies
conducted at Wright-Patterson Air Force
Base, Gaworski, MacEwen, Vernot, and
co-workers exposed beagle dogs, F344 rats,
and C57BL/6 mice for 90 days to JP-5 fuel
vapors from either petroleum or shale oil
sources [summarized in Gaworksi et al.
(51) and MacEwen and Vernot (52)].
Hematocrit, hemoglobin, total erythro-
cytes, total leukocytes, differential counts,
mean corpuscular volume, and mean
corpuscular hemoglobin concentrations
were determined. Beagle dog blood para-
meters remained within normal limits,
although a slight erythrocyte osmotic
fragility was observed after 90 days expo-
sure at 750 mgm-3. No other significant
changes were observed. Some fluctuations
oferythrocyte levels were observed in rats,
accompanied by slight changes in hemat-
ocrit and hemoglobin. No hematological
effects were observed in C57BL/6 mice.
Pathological studies of F344 rats and
C57BL/6 mice showed no dose-related
increases in leukemia in rats and no signifi-
cant exposure-related effects in mice.
Liver toxicity ofJP-5 has been studied
in experimental rodents. Parker et al. (53)
administered oral doses ofJP-5 to male
Sprague-Dawley rats and observed an oral
LD50 of >60 ml kg-'. Animals that died
during the 40-day holding period had
swollen, mottled livers and histopathologic
evaluation of the survivors indicated
hepatic periportal fatty changes. Similar
studies using single oral doses ofJP-5 fol-
lowed by sacrifices over the next three days
showed a clear pattern of liver injury
accompanied by increased serum lactate
dehydrogenase, glutamic-transaminase, and
glutamic-pyruvate transaminase levels
(53,44,54). Inhalation exposures ofbeagle
dogs, F344 rats, and C57BL/6 mice were
conducted as part ofthe Wright-Patterson
studies (55). Immediately after exposure
ended, the dogs exhibited diffuse mild
swellings and clouding of hepatocytes
which later were described as containing
excess glycogen. Beagle dog exposures to
750 mg m-3 resulted in increased liver
weights, increased liver/body weight ratios,
and decreased glutamic-pyruvate transami-
nase levels. Rats showed no histopathology
or serum enzyme changes immediately
after exposure, but after 19 to 21 months
there was mild hepatic hyperplasia. Exposed
female mice in the same studies showed
focal fatty changes in hepatocytes that
stained positive for fat and mild diffuse
cytoplasmic vacuolization that was negative
for fat and glycogen only in the 750mgm-3
exposure group. These changes resolved by
19 to 21 months post-exposure. In a study
involving intermittent exposures (6 hr/day,
5 days/week for 6 weeks) ofrats to 1100 or
1600 mg m-3 ofJP-5, Bogo et al. (54)
reported no adverse effects in the liver and
no change in serum enzyme levels.
Central nervous system (CNS) toxicity,
generally classified under narcosis or gen-
eral anaesthesia, is common to all volatile
hydrocarbons (56,57) and is similar to (or
the same as) the narcosis effects of, for
example, diethyl ether, nitrous oxide, or
halothanes (58). For example, Davies (59)
described an incident in which a jet pilot
was exposed to JP-4 vapors from a leaking
fuel line during take off. He reported feel-
ing groggy and weak and landed immedi-
ately. He exhibited a staggering gait,
slurred speech, and signs ofearly anesthesia
that were confirmed on physical examina-
tion. The pilot reported that he did not
feel normal 36 hr after the event but
appeared in good condition during the
next few days and upon reexamination 5
months later. Estimated exposure concen-
tration was 24,000 to 56,000 mg m-3 for a
period ofapproximately 20 min.
It is assumed that this toxic effect is not
compound-specific and is linked to the dis-
solution ofthe xenobiotic molecules in the
cell membrane of (a.o.) nerve cells, thereby
disrupting their normal operation and
leading to depressed nerve cell action. There
is a direct connection between a com-
pound's hydrophobicity (expressed as its log
Kow) and its efficacy as a general anesthetic
(58). The achievable depth ofanesthesia is
related to the minimum alveolar concentra-
tion necessary to produce anesthesia. The
rate of anaesthetic onset is related to the
blood/gas partition coefficient; for low
ratios, onset is rapid and for high ratios
onset is slow.
Chronic effects, following either pro-
longed (semi)continuous exposure to low
or intermediate doses (concentrations) of
JP-5 or acute exposure to extremely high
concentrations, can tentatively be classified
as Psycho-organic Solvent Syndrome (60),
a condition characterized by general feelings
ofdepression and inadequacy in the early
stages and by concentration problems, loss
ofmemory, impairment ofmental abilities,
and possibly dementia on prolonged expo-
sure (several years or more). This condition
seems to be slowly reversible in the initial
(depression-like) stages but is only partly or
nonreversible after onset ofthe more seri-
ous symptoms. The causative mechanism of
this toxicological syndrome is not known,
but one suggestion is that it might be
linked to progressive demyelinization of
nerve cell axons caused by the exposure to
solvents. This effect might then also be
linked to a compound's hydrophobicity,
indicating its solvation potential to fatty
molecules. However, attribution of a
chronic neurological syndrome to solvents
or other organic chemical exposures has
been controversial (61).
Data on chronic human exposure to jet
fuels is limited. Knave and co-workers
reported on two groups of aircraft factory
workers exposed to jet fuels in the course
of their daily activities (62-66). No con-
trols were available for this study. Reported
symptoms ofexposure included dizziness,
headache, nausea, palpitations, and feeling
ofpressure on the chest during acute expo-
sures at work. Chronic symptoms included
neurasthenia, psychasthenia, and symptoms
indicative of polyneuropathy. Clinical
evaluation ofnerve conduction velocity and
vibration threshold revealed no remarkable
findings. However, analysis ofthese exposed
workers and reference groups by the authors
led them to conclude that the jet fuel-
exposed workers demonstrated a higher
than expected prevalence of these symp-
toms. In a study designed to obtain more
information on chronic neurological effects
ofjet fuels, Knave et al. (64) conducted a
second study ofworkers in ajet engine fac-
tory. From this study they concluded that
there was a higher prevalence of neuras-
thenic symptoms, greater irregularity of
complex reaction time test performance
results, greater performance decrement
over time for simple reaction time test
performance, and poorer performance in
perceptual speed tasks.
In light of the above toxicological
profile, it is concluded that our first aim in
modeling the toxicity and toxicokinetics of
JP-5 should be modeling ofacute intoxica-
tion through noncompound-specific narco-
sis. The effect is assumed to be purely
toxicokinetics driven and well correlated to
the final concentration of compound in a
lipoid tissue, presumably the nerve cell
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membrane. This dose metric in principle is
amenable to PBPK modeling. Constructing
such a model should therefore be the first
stage in the risk assessment ofJP-5, accord-
ing to the approach described here.
HowDoWeObtaintheNecesary
Pharmacokinetic Parameters and
Toxicoloical infomation?
Partition Coefficients. It appears that
partition coefficients constitute essential
parameters for the modeling of distribu-
tion, as well as distribution-linked toxic
effects ofJP-5. Therefore, it is important
to gain information on the hydrophobicity
profile ofJP-5 and/or its constituents.
Approach 1: The noncompound-specific
approach. Since most if not all toxic
effects expected from exposure to JP-5 are
noncompound-specific, it should not be
necessary to identify and quantify indi-
vidual components ofJP-5 (vapor) to
model the distribution and effects ofJP-5
in humans [see, for example, Verhaar et al.
(67)]. A nonspecific hydrophobicity profile
could possibly suffice. To this end, an
assaywas recently devised by Hermens and
Verbruggen (68) based on work byVerhaar
et al. (67) in which a chemical mixture is
separated byC18-reversed phase HPLC and
the effluent is pooled into equally spaced,
log KO-related windows. The total amount
ofcompounds present in any one pool, on
a molar basis, is then quantified by vapor
pressure osmometry. The outcome of this
procedure is a profile of a mixture that
indicates, in window averages of 1 log
unit, the mole fractions of a mixture in
each window. These windows, together
with the data on mole fraction contained
in them, can then be used as a set ofsurro-
gate components ofJP-5, about which all
necessary information is known, namely
amount, (average) hydrophobicity, and
toxic action.
Approach2. Compound-specificapproaches.
If a compound-specific approach is pre-
ferred, JP-5 samples could be character-
ized using gas chromatography (GC) or
gas chromatography-mass spectography
(GC-MS) techniques, and the major com-
ponents, up to a total w/w percentage of
ideally 60 to 95%, identified and quan-
tified. Log Kow values could then be either
retrieved or generated for each of the
identified components and the behaviour
ofJP-5 modeled as the joint (additive)
action ofall these individual components.
Alternatively, the approach mentioned
in the Composition section, where JP-5 is
described based on partial composition
data, assuming the unknown fraction is
similar in hydrophobicity profile to the
known fraction, could be used to generate
a compound-specific partition coefficient
profile ofJP-5.
Additionally, knowledge or partial
knowledge about the composition ofJP-5
would allow a functional lumping analysis,
based on the hydrocarbon block method
(69-71), thereby greatly reducing the com-
plexity ofthe subsequent modeling process
(not unlike when using the surrogate com-
ponents). The hydrocarbon block method
is an approach in which based on knowl-
edge ofthe (preferably exact) composition
of a hydrocarbon mixture, one assigns
each constituent to a certain pseudocom-
pound based on its hydrophobicity (log
K,). The pseudocompounds are normally
chosen to represent consecutive 1 log unit
Kowwindows.
Physiological Partition Coefficients. Ifa
compound-specific approach is taken, the
literature could be searched for physio-
logical partition coefficients for individual
components. For those components for
which no such partition coefficients are
available, or for the surrogate components if
the noncompound-specific approach is
taken, the formulae developed by DeJongh
et al. (35) can be used to predict the differ-
ent physiological partition coefficients from
log Kow values and physical parameters for
the appropriate compartments. This is a
very elegant and valid approach for the
prediction oftissue partition coefficients.
Vapor Composition. Since our main
interest is the modeling of effects from
inhalation exposure to JP-5 fumes, we
should be concerned with the composition
ofJP-5 vapor instead ofJP-5 liquid bulk,
which will show considerable differences.
Bishop et al. (45) showed that the average
molar mass of the liquid bulk of a JP-4
sample was 125 g, whereas the molar mass
ofthe associated headspace vapor was 85 g.
Note that the observed difference will be
less pronounced forJP-5 because ofits nar-
rower overall boiling range with a higher
low end. This specific problem could be
tackled in two ways. First, for any of the
analytical methods described above in the
Partition Coefficients section, the sample
to be analyzed could be taken from a con-
trolled JP-5 headspace instead offromJP-5
bulk liquid. Alternatively, vapor pressures
or Henry's law constants could be pre-
dicted from hydrophobicity profiles as gen-
erated by the Verbruggen method (68).
The vapor pressure prediction procedures
have been developed and partially tested,
but have yet to be published (Verbruggen,
personal communication).
Biotransformation (Metabolism).
There are known biotransformation path-
ways for a number of identified or sus-
pected constituents ofJP-5. Examples are
toluene (converted to nontoxic benzoic
acid, then converted to hippuric acid and
excreted) and styrene (converted to man-
delic acid, then converted to phenylgly-
oxylic acid). Hexane, which is converted to
the highly neurotoxic 2,5-hexanedione, is
not expected in JP-5, although it is a con-
stituent ofJP-4 and gasoline. Specific
metabolic pathways for other (higher) n-
alkanes and branched alkanes undoubtedly
exist and a literature search could be done
to uncover the primary metabolic routes
for paraffinic, olefinic, aromatic, and naph-
thenicjet fuel constituents.
Again, this aspect can be approached in
different ways. Ifa noncompound-specific
approach is taken, a generalized metabolic
pathway may be indicated for each of a
number ofclasses ofchemicals (namely N-
alkanes, branched alkanes, alkenes, alkyl-
substituted benzenes, alkenyl-substituted
benzenes, naphthenes, and PAHs); most
metabolites will be detoxifying, meaning
that they will be less toxic, more water-sol-
uble, and more easily excreted than their
parent compounds. It should be kept in
mind, however, that exceptions do exist.
For these metabolic pathways, generalized
rate constants could be used; these rate
constants could either be predicted, based
on QSAR models, or taken as literature
values for appropriate example compounds
if available. Distribution of compound
classes over high performance liquid chro-
matography (HPLC) pools (surrogate com-
ponents) could be considered uniform
(zeroth order approximation) or could be
predicted from nuclear magnetic resonance
(NMR) or IR profiles measured on the
individual pools.
If a compound-specific approach is
taken (either exhaustive or model-com-
pound-based), metabolic pathways for each
ofthese compounds plus appropriate rate
constants could be extracted from the liter-
ature or databases or, ifunavailable, pre-
dicted using QSAR methods. A literature
search for published rate constants would
then have to be carried out.
Reactivity. Since reactivity is expected
to be a minor ifnot negligible, factor inJP-
5 toxicity, a sophisticated approach does
not appear necessary except, perhaps, for
metabolism. Some nonspecific reactivity
might in principle be expected due to the
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presence ofunsaturated aliphatic moieties,
especially if the unsaturations are conju-
gated with other aliphatic or aromatic
unsaturations. Assuming a surrogate com-
ponent approach, it might be enough just
to determine the amount ofolefins present
in any single surrogate component (HPLC
pool; log Kow window); a feasible way to
achieve this would be by running an NMR
or IRprofile ofeach HPLC pool.
Carcinogencity. The same reasoning as
for reactivity also holds for carcinogenicity.
JP-5 is tentatively classified as noncarcino-
genic. If, however, some attention is given
to the modeling ofpossible carcinogenic
behavior ofJP-5, one consideration might
be to estimate the fraction ofaromatic moi-
eties in each surrogate component, to model
tissue distribution and retention ofpossible
carcinogens. Again this could be achieved by
running an NMR or IR profile of each
HPLC pool. Note, however, that the only
real carcinogen from this group, namely
unsubstituted benzene, is not present in any
significant amount inJP-5.
SomeAdditional Notes onMixure
ToxicityofJP-5 Impliated
Compounds
Additivity versus Nonlinear Interactions.
It is generally assumed that acute general
anesthesia, which is most likely associated
with some sort ofdisruption of nerve cell
membrane function through dissolution of
narcotic compounds in these membranes
(there are competing theories ofgeneral
anesthesia, but to date none have been
substantiated, and the one presented here
can be regarded as the most parsimonious
one), is an additive process, since no specific
interactions appear involved and there is a
very large receptor (cell membrane)/sub-
strate ratio. Moreover, unless proof to the
contrary is encountered, it is probably safe
to assume that chronic Psycho-organic
Solvent Syndrome is also an additive mecha-
nism, expressed on an active-compound
basis (i.e., excluding nontoxic metabolites).
Moreover, it has been and can be shown
that even in mixtures of explicitly nona-
dditive (either synergistic, potentiating, or
antagonistic) chemicals, the overall effect
of a mixture tends toward an additive,
narcotic limit for n approaching infinity,
with n being the number of compounds
in a mixture, provided the mixture has
approximately equal distribution ofcom-
pound mole fractions [(72), see also
Berenbaum (40)]. This phenomenon is
ascribed to the notion that for such a mix-
ture individual compounds or groups of
compounds acting on the same receptor or
by the same mechanism, are generally pre-
sent at concentrations below their pharma-
cologic/toxicologic threshold level. The
one thing they then have in common is
their ability to partition into membranes
and elicit narcosis; since all compounds in
principle have this ability, and simple nar-
cosis is an additive phenomenon based on
molar units, the associated joint toxic
action is additive.
Conclusions
Over the last decades, a number oftech-
niques have been developed, and a number
ofadvances have been made in the fields of
chemical, toxicological, and computational
sciences that when combined offer for the
first time in the study ofthe toxicology of
chemical mixtures the possibility ofactu-
ally predicting some aspects ofthe toxicity
of said mixtures. In this paper we have
introduced and briefly described three
techniques we think will form the corner-
stones ofpredictive toxicology for (com-
plex) chemical mixtures in the near future.
These three techniques are: QSAR analysis,
which can be used to predict needed
physicochemical and toxicological parame-
ters for unknown compounds or for surro-
gate compounds; lumping analysis, which
can drastically reduce the complexity ofthe
description ofa mixture while reporting the
error introduced by a particular level of
simplification so the artificially introduced
error can be kept within reasonable limits;
and PBPK/PD modeling, which can be
used to describe the toxicokinetics (and
possibly the toxicodynamics) ofan ensem-
ble ofcompounds or lumped pseudocom-
pounds, including possible interaction
effects. In combination, these three tools
can be used to predict target organ/site lev-
els ofindividual compounds or the entire
mixture from exposure data-or conversely,
they can be used to set safe exposure levels
given threshold target site doses or dose-
time combinations. This enables one to
deal with the predicted toxicity ofcomplex
mixtures in a more integrated way than just
focusing on one or two major components;
moreover, it offers an approach to predict at
least some toxicological aspects ofunknown,
orpartiallyknown, orvariable mixtures.
We have illustrated this approach by
describing how it can be applied to the inte-
grated riskassessment ofa navyjetfuel,JP-5,
a complex mixture ofmainly hydrocarbons.
We realize that some parts ofthis example
have been worked out more completely than
others, and that we did not (yet) present an
actual model for the toxicokinetics and
dynamics ofJP-5. We do, however, have a
preliminary working model for the pharma-
cokinetics ofhydrocarbon mixtures based on
the hydrocarbon block method and the
partition coefficient QSARs developed by
De Jongh et al. (35), written in Advanced
Continuous Simulation Language (ACSL)
(73). A copy ofthis model is available from
theauthors on request.
Appendix: How to Minimize Error in Lumping
Lumping two or more discrete compounds
into one pseudocompound to decrease the
complexity ofdescription of a mixture will
introduce error into a model because the
different physicochemical or other parame-
ters for the separate compounds are being
replaced by averaged parameters for the
pseudocompound. How can this error be
minimized? We discuss a method to do just
that, employing alumpingapproach for sim-
ple mono-exponential kinetic rate constants
as an example; note that the same approach
can be used forlumping on any parameter.
Single-component
Representation of a
Composite Linear System's
Concentration: Discounted
Least Squares
Let there be a linear system ofthe following
form:
dCj(t)=-kjCj(t) dt -11t (A.1)
so that
Cj(t) =Cj(O)e-kJt (A.2)
Therefore, the total concentration at
time tofall components is
C(t) = YCj(O)ei
j=,
= Je-ktdG(k)
0
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The latter representation is arrived at if
we order the (positive) k1s in order ofsize,
kl<k2< ... kj, and think of G(k) as having
jumps (saltuses) of magnitude Cj(O) at
k= ki, k= k2, ..., k= kj. This means that
00 J
|dG(k) =G(oo) = 0C1(O) = C
0 j=1
define G(k) as G(k)lCso G(oo)=1. It can
be seen that C(t) is the Laplace-Stieltjes
transform ofthe mixing discrete distribu-
tion. This distribution summarizes the
between-component variability in the cur-
rent simple system.
Now consider replacing the above sys-
tem with asingle-component (S-C) system:
C(t;K) = Celt (A.4)
The problem is to determine the (single)
summarizing rate parameter, K. We do so
by assigning a penalty for lack-of-fit ofthe
S-C representation to the true function.
DiscountedLeast-Squares Fitof
Single Component
Put
co ~~~~~2
S1(K;6) =J(C(t;K)-C(t)) e dt. (A.5)
0
Notice that, for any K, this considers an
error or fit-discrepancy at every t, namely
C(t;K)-C(t) and squares it; then each such
squared error is multiplied by a discount
factor, e-Otthat, for6 >0, weights the early
discrepancies more extensively than those
occurring later in time. Finally, all such dis-
counted squared discrepancies are added
(integrated) to obtain the fit score, S1(K;6);
this value is the best single component to
represent the mixture. Observe that
S1(K;o) = ICea -Je-ktdG(k) *e6@dt.
0 0
(A.6)
To minimize, differentiate on K and
equate the derivative to zero:
dS =
-
Ce-Kt
-|ekdG(k)1 dKc o °
(A.10)
This leads to the equation
Cte (2 dt jdG(k)te(2K++k)tdt.
0 0 0
(A.I
Perform the time-integration to find
2, =JdG(k) 2 (A
(2K+6
0 (Kc+0+k)2 A
or
- dG(k) (2K +6)2
o C2
7-,y2Kv+6e JdG-(k) +6 ) =1,
where we have used the fact that
fdG(k) =C, so fdU(k) =U(oo) =1.
0 0
Notice that the factor
2K+0 2
iK+O+k)
increases from
O+k <1
at K=0 to 4 when K-+oo; consequently, at
least one solution of (A.10) always exists
if G(k) has strictly positive support. Note
that if G(k) concentrates at k=ki, e.g.,
3.2, and therefore there is just that single
component, then (A.10) becomes
2K+0 +
K+0+k)=
JdG(k)( 2K + 0
2
= K+6+k)+1 2K = 8) 2 o+k1c +0+k 2) 1(2 \~~2
2
.8) 2 K+6+kl 2"~K+6+k2, =
1 1
(icf6+k1)2 + ( k2)2
1
9q) -
1(2K+)2 2
(A.12)
or
Both L(K) and R(K) are monotone
decreasing, but
L(°) = I)2 (+ <)2 R(2);
however, L(K) decreases less rapidly than
R(K), so a single intersection occurs at
K>0. This is the desired single-component
rate. It is, ofcourse, a function of 0, and
the larger is 6 the less do the particular
values kI and k2 influence the result, since
the more decisively large time effects are
made insignificant. On the other hand, let
kl<k2, and let k2 become very large. In the
extreme case when k2=oo, we must solve
1 2
(K+e+k)2 (2K+e)2'
so
2K+40 = (K+6+k1);
Cosq .2uent=ly- 0+
Consequently,
(A.11)
which is only satisfied when K =kl. So our
method is consistent to the degree that it
recaptures a single component.
Next check for a two-component sys-
tem. Put C1(0)=QG(0), so
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L(c) = R(K). (A.13)
(A.14)
A _ 5 (-I +4kj
and if0=0 (smallestdiscounting),
A 2ki -= 1.414k, =
2- -2 2-1.414 (A.15)
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The algorithm struggles to imitate the
combined effect ofa very fast component
and a slower one by increasing the lower
one's rate, and this is at least qualitatively
appropriate.
Weighted Discounted Least-Squares
Fit ofSingle Component
Reviewthe above to see that there is freedom
to alter the basic fit-score function, S1(K;6O)
without destroying its tractability. We give
some examples.
Example 1: Power-of-time (Gamma)
Weighting/Discounting. Replace e-ot in
(A.5) by
w(t;0;13) = e-@' (6t) '6 O < A1
This essentially concentrates on errors near
the time-valueP/0so it tends to find K that
centers e-Kct near the middle ofthe individ-
ual e-kitvalues, where t /3/60.
The analysis is tractable: differentiation
on K now gives
dSo = J2(Ce-t' - le-ItdG(k)1
C (-)te-`e- t(r6t/A dt. (A.17)
Set the derivative equal to zero to produce
the equation
0e20 t0
d fe-2it .e-ot (J)f
= |dG(k)je-(k+)t . e- (0t)00dt
(A.18)
Known Laplace transform formulas now
give
oY
+I
( ~ P+1
(2+ f) =JdG(k)(1 6+
or
fdG(k)( 222 f (A.19)
which can be solved for K.
Example 2: Reverse-Exponential
Discounting. Suppose we want a weight
scheme that concentrates on and attempts
to minimize all errors that occur at large
times. One way is to replace e-Ot in (A.5)
with
w(t;0)=1-e-t. (A.20)
This can be put into equations (A.6) to
(A.9) and the resulting equation solved.
Details are omitted.
Example 3: Fraetional (Percent)
ErrorMinimization. If
00
e-Kt -fektdU(k)
0
is the absolute error made in estimating by
ct, a version offractional error in doing
so is
e-lct fe-ktdU(k)
0K 1e-Kt -ktdU(k). -Kt
e 0
(A.21)
Thus,
S1(C;e) = J I -etJe-ktdU(k) w(t;6).
O o
(A.22)
Differentiate; set result equal to zero:
dS, ( k -
-=2 i-ejfe ktdU(k) e te =0. dic ok 0
(A.23)
We get
1 jdGk) 1
(o-I)2 0 (k (O+k-2k )2- (A.
(A.24)
Solve for ic. Other weightings are also
possible.
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